Table of Content

Global Vulvar and Vaginal Atrophy Therapy Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Vulvar and Vaginal Atrophy Therapy Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Vulvar and Vaginal Atrophy Therapy Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Vulvar and Vaginal Atrophy Therapy

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Vulvar and Vaginal Atrophy Therapy Sales Channel and Distributors Analysis
3.3.1 Vulvar and Vaginal Atrophy Therapy Sales Channel
3.3.2 Vulvar and Vaginal Atrophy Therapy Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospitals
3.4.2 Major Buyers in Ambulatory Surgical Centers
3.5 Vulvar and Vaginal Atrophy Therapy Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Vulvar and Vaginal Atrophy Therapy Type Introduction
4.1.1 Vulvar Atrophy Therapy
4.1.2 Vaginal Atrophy Therapy
4.2 Global Vulvar and Vaginal Atrophy Therapy Sales by Type 2016-2021
4.3 Global Vulvar and Vaginal Atrophy Therapy Revenue by Type 2016-2021
4.4 Global Vulvar and Vaginal Atrophy Therapy Price by Type 2016-2021

5 Market Segment: by Application
5.1 Vulvar and Vaginal Atrophy Therapy Type Introduction
5.1.1 Hospitals
5.1.2 Ambulatory Surgical Centers
5.1.3 Specialty Clinics
5.1.3 Others
5.2 Global Vulvar and Vaginal Atrophy Therapy Sales by Application 2016-2021
5.3 Global Vulvar and Vaginal Atrophy Therapy Revenue by Application 2016-2021
5.4 Global Vulvar and Vaginal Atrophy Therapy Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Vulvar and Vaginal Atrophy Therapy Market by Region
6.1.1 Global Vulvar and Vaginal Atrophy Therapy Sales by Regions
6.1.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Regions
6.2 North America Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.3 Europe Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.4 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.5 South America Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.6 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market 2016-2021

7 North America
7.1 North America Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
7.1.1 North America Vulvar and Vaginal Atrophy Therapy Sales by Country
7.1.2 North America Vulvar and Vaginal Atrophy Therapy Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
8.1.1 Europe Vulvar and Vaginal Atrophy Therapy Sales by Country
8.1.2 Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
9.1.1 Asia Pacific Vulvar and Vaginal Atrophy Therapy Sales by Country
9.1.2 Asia Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
10.1.1 South America Vulvar and Vaginal Atrophy Therapy Sales by Country
10.1.2 South America Vulvar and Vaginal Atrophy Therapy Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
11.1.1 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country
11.1.2 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Viveve
12.1.1 Viveve Company Information
12.1.2 Viveve Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.1.3 Viveve Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Viveve Key Development
12.2 VenusConcept
12.2.1 VenusConcept Company Information
12.2.2 VenusConcept Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.2.3 VenusConcept Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 VenusConcept Key Development
12.3 ThermiGen LLC
12.3.1 ThermiGen LLC Company Information
12.3.2 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.3.3 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 ThermiGen LLC Key Development
12.4 Lutronic
12.4.1 Lutronic Company Information
12.4.2 Lutronic Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.4.3 Lutronic Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Lutronic Key Development
12.5 Hologic
12.5.1 Hologic Company Information
12.5.2 Hologic Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.5.3 Hologic Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Hologic Key Development
12.6 Fotona
12.6.1 Fotona Company Information
12.6.2 Fotona Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.6.3 Fotona Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Fotona Key Development
12.7 BTL Group of Companies
12.7.1 BTL Group of Companies Company Information
12.7.2 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.7.3 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Fotona Key Development
12.9 Alma Lasers
12.9.1 Alma Lasers Company Information
12.9.2 Alma Lasers Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.9.3 Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Alma Lasers Key Development
12.8.1 Almirall Company Information
12.8.2 Almirall Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.8.3 Almirall Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Almirall Key Development

13 Global Vulvar and Vaginal Atrophy Therapy Market Forecast by Region by Type and by Application
13.1 Global Vulvar and Vaginal Atrophy Therapy Sales, Revenue Forecast 2022-2027
13.2 Global Vulvar and Vaginal Atrophy Therapy Forecast by Regions
13.2.1 Global Vulvar and Vaginal Atrophy Therapy Sales Forecast by Region 2022-2027
13.2.2 Global Vulvar and Vaginal Atrophy Therapy Revenue Forecast by Region 2022-2027
13.3 Global Vulvar and Vaginal Atrophy Therapy Forecast by Type
13.3.1 Global Vulvar and Vaginal Atrophy Therapy Sales Forecast by Type 2022-2027
13.3.2 Global Vulvar and Vaginal Atrophy Therapy Revenue Forecast by Type 2022-2027
13.3.3 Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Type 2022-2027
13.4 Global Vulvar and Vaginal Atrophy Therapy Forecast by Application
13.4.1 Global Vulvar and Vaginal Atrophy Therapy Sales Forecast by Application 2022-2027
13.4.2 Global Vulvar and Vaginal Atrophy Therapy Revenue Forecast by Application 2022-2027
13.4.3 Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer